Blasticon Biotechnologische Forschung GmbH
About Blasticon Biotechnologische Forschung
Blasticon is a biotechnology company active in the fields of cellular medicine and in vitro diagnostics. Blasticon has a proprietary technology based on which monocytes (mature white blood cells) from patient blood can be recycled into stem cell-like human cells and differentiated into various functional cells for versatile applications. The company was founded in 2002.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Biotechnology